235 related articles for article (PubMed ID: 1836124)
1. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
Bara A; Socaciu C; Silvestru C; Haiduc I
Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
[TBL] [Abstract][Full Text] [Related]
2. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
Silvestru C; Socaciu C; Bara A; Haiduc I
Anticancer Res; 1990; 10(3):803-4. PubMed ID: 2369094
[TBL] [Abstract][Full Text] [Related]
3. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
Socaciu C; Bara A; Silvestru C; Haiduc I
In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
Kato T; Fukushima M; Kurozumi S; Noyori R
Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
[TBL] [Abstract][Full Text] [Related]
5. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
6. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
8. Organometallic compounds in oncology: implications of novel organotins as antitumor agents.
Alama A; Tasso B; Novelli F; Sparatore F
Drug Discov Today; 2009 May; 14(9-10):500-8. PubMed ID: 19429510
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic potential of the volatile oils from Zanthoxylum rhoifolium Lam leaves.
da Silva SL; Figueiredo PM; Yano T
Eur J Pharmacol; 2007 Dec; 576(1-3):180-8. PubMed ID: 17716654
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
Elo HO; Lumme PO
Cancer Treat Rep; 1985 Sep; 69(9):1021-2. PubMed ID: 4028035
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of proliferation of Ehrlich ascites carcinoma cells in vitro and in vivo by halogeno analogues of long chain acyl- and alkylglycerols.
Langen P; Brachwitz H; Schildt J
Acta Biol Med Ger; 1979; 38(7):965-74. PubMed ID: 543374
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure, electrochemistry and spectral characterization of (D-glucopyranose)-4-phenylthiosemicarbazide metal complexes and their antitumor activity against Ehrlich ascites carcinoma in Swiss albino mice.
Sathisha MP; Budagumpi S; Kulkarni NV; Kurdekar GS; Revankar VK; Pai KS
Eur J Med Chem; 2010 Jan; 45(1):106-13. PubMed ID: 19854545
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activities of spirogermanium and other structurally related azaspiranes: effects on tumor cell and macrophage functions.
Mirabelli CK; Badger AM; Sung CP; Hillegass L; Sung CM; Johnson RK; Picker D; Schwartz D; Dorman J; Martellucci S
Anticancer Drug Des; 1989 Mar; 3(4):231-42. PubMed ID: 2930625
[TBL] [Abstract][Full Text] [Related]
14. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.
Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN
Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of an alkylating derivative of dipyridamole.
Andreani A; Bossa R; Fraccari A; Galatulas I; Ninci MA; Rambaldi M
Anticancer Res; 1996; 16(4A):1831-3. PubMed ID: 8712709
[TBL] [Abstract][Full Text] [Related]
16. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
Sur P; Bag SP; Sur B; Khanam JA
Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
Shenoy BD; Udupa N; Kamath R; Devi PU
Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound.
Barbieri F; Viale M; Sparatore F; Favre A; Cagnoli M; Bruzzo C; Novelli F; Alama A
Anticancer Res; 2000; 20(2A):977-80. PubMed ID: 10810384
[TBL] [Abstract][Full Text] [Related]
19. [Studies on antitumor effects of guanidino compounds and complexone derivatives (author's transl)].
Nagai T
Igaku Kenkyu; 1978 Jun; 48(5):333-467. PubMed ID: 102101
[No Abstract] [Full Text] [Related]
20. Alkylphosphonium salts as a new class of antitumor agents.
Sanyal U; Chatterjee RS; Das SK; Chakraborti SK
Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
